Dual-site spatiotemporal and simultaneous inhibition on PIN1 via arsenic-retinoic albumin nanoparticles enables synergistic oncotherapy
Dayun Yang, Jianping Wang, Ruoru Liu, Jinfa Chen, Haiying Wen, Yu Li, Bo Lu, Zhao Guo, Daxiang Cui, Lee Jia, Haiyan Dong · 2025
Read Dual-site spatiotemporal and simultaneous inhibition on PIN1 via arsenic-retinoic albumin nanoparticles enables synergistic oncotherapy by Dayun Yang, Jianping Wang, Ruoru Liu, Jinfa Chen, Haiying Wen, Yu Li, Bo Lu, Zhao Guo, Daxiang Cui, Lee Jia, Haiyan Dong (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12837326.txt.
Description
Pin1 is an enzyme that twists other proteins into new shapes, and many cancers lean on it to grow and spread. Dayun Yang, Jianping Wang, and Ruoru Liu led a team that attacks Pin1 with two known drugs at once. They fused retinoic acid and arsenic trioxide onto albumin, a blood protein, forming tiny particles that carry both drugs to the tumor together.
The particles released their cargo slowly and piled up in tumors. In dishes they slowed liver cancer growth and movement far better than the free drugs. In mice they shrank tumors and cut lung spread without harming blood or organs. Protein mapping showed the pair shut down more of Pin1's cancer networks than either drug alone.
Catalog record
| CREATOR | Dayun Yang, Jianping Wang, Ruoru Liu, Jinfa Chen, Haiying Wen, Yu Li, Bo Lu, Zhao Guo, Daxiang Cui, Lee Jia, Haiyan Dong |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 74 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |